JPH0353869A - Food containing highly unsaturated fatty acid - Google Patents
Food containing highly unsaturated fatty acidInfo
- Publication number
- JPH0353869A JPH0353869A JP1187256A JP18725689A JPH0353869A JP H0353869 A JPH0353869 A JP H0353869A JP 1187256 A JP1187256 A JP 1187256A JP 18725689 A JP18725689 A JP 18725689A JP H0353869 A JPH0353869 A JP H0353869A
- Authority
- JP
- Japan
- Prior art keywords
- fatty acids
- acid
- fatty acid
- omega
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 16
- 235000021122 unsaturated fatty acids Nutrition 0.000 title claims description 9
- 150000004670 unsaturated fatty acids Chemical class 0.000 title claims description 9
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims abstract description 26
- 229940012843 omega-3 fatty acid Drugs 0.000 claims abstract description 23
- 235000020665 omega-6 fatty acid Nutrition 0.000 claims abstract description 22
- 229940033080 omega-6 fatty acid Drugs 0.000 claims abstract description 22
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 14
- 229930195729 fatty acid Natural products 0.000 claims abstract description 14
- 239000000194 fatty acid Substances 0.000 claims abstract description 14
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 239000006014 omega-3 oil Substances 0.000 claims description 18
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract description 13
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 abstract description 6
- 206010006187 Breast cancer Diseases 0.000 abstract description 4
- 208000026310 Breast neoplasm Diseases 0.000 abstract description 4
- 206010020772 Hypertension Diseases 0.000 abstract description 4
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract description 3
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract description 3
- 235000020664 gamma-linolenic acid Nutrition 0.000 abstract description 3
- 229960002733 gamolenic acid Drugs 0.000 abstract description 3
- 208000019622 heart disease Diseases 0.000 abstract description 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 abstract 2
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 abstract 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 1
- SBHCLVQMTBWHCD-UHFFFAOYSA-N icosa-2,4,6,8,10-pentaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC(O)=O SBHCLVQMTBWHCD-UHFFFAOYSA-N 0.000 abstract 1
- 201000011061 large intestine cancer Diseases 0.000 abstract 1
- 229960004232 linoleic acid Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 8
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 6
- 229940090949 docosahexaenoic acid Drugs 0.000 description 6
- 229960004488 linolenic acid Drugs 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 235000020778 linoleic acid Nutrition 0.000 description 5
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 235000004347 Perilla Nutrition 0.000 description 4
- 244000124853 Perilla frutescens Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 235000021323 fish oil Nutrition 0.000 description 4
- 150000002617 leukotrienes Chemical class 0.000 description 4
- 239000008268 mayonnaise Substances 0.000 description 4
- 235000010746 mayonnaise Nutrition 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- 229920000858 Cyclodextrin Polymers 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241000269851 Sarda sarda Species 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013310 margarine Nutrition 0.000 description 3
- 239000003264 margarine Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 3
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 150000003180 prostaglandins Chemical class 0.000 description 3
- 235000013580 sausages Nutrition 0.000 description 3
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003026 cod liver oil Substances 0.000 description 2
- 235000012716 cod liver oil Nutrition 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 235000008524 evening primrose extract Nutrition 0.000 description 2
- 239000010475 evening primrose oil Substances 0.000 description 2
- 229940089020 evening primrose oil Drugs 0.000 description 2
- 235000021027 japanese diet Nutrition 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000013923 monosodium glutamate Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- FZIPCQLKPTZZIM-UHFFFAOYSA-N 2-oxidanylpropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FZIPCQLKPTZZIM-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000273930 Brevoortia tyrannus Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 238000006563 Carroll rearrangement reaction Methods 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000951471 Citrus junos Species 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- -1 PGF2α and TXA2 Chemical class 0.000 description 1
- 241001098054 Pollachius pollachius Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019465 surimi Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Seasonings (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Edible Oils And Fats (AREA)
- Fish Paste Products (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は高度不飽和脂肪酸を含む食品に関するものであ
る。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to foods containing highly unsaturated fatty acids.
(従来の技術)
高度不飽和脂肪酸には代表的な2つの系列ω3脂肪酸お
よびω−6脂肪酸がある(ωとは、脂肪酸のメチル基末
端から数えて最初の二重結合がある炭素ま゛での数を示
している)。(Prior art) There are two representative series of highly unsaturated fatty acids: ω3 fatty acids and ω-6 fatty acids (ω is the carbon where the first double bond is located counting from the end of the methyl group of the fatty acid. ).
ω−6脂肪酸の例としては、リノール酸、Tリノレン酸
、アラキドン酸、また、ω−3脂肪酸の例としては、α
−リノレン酸、エイコサベンクエン酸、ドコサヘキサエ
ン酸などが挙げられる。Examples of ω-6 fatty acids include linoleic acid, T-linolenic acid, arachidonic acid, and examples of ω-3 fatty acids include α
- Linolenic acid, eicosaben citric acid, docosahexaenoic acid, etc.
ここで我々日本人の摂取脂肪酸を分析してみると、ω−
6に大きく偏っている。これは、ω−6脂肪酸が鳥獣肉
類、卵製品、乳製品、コーンやサフラワーなどの植物油
に含まれており、我々の食卓には欠かせないものとなっ
ているからである。When we analyze the intake of fatty acids in Japanese people, we find that ω-
It's heavily biased towards 6. This is because omega-6 fatty acids are contained in poultry meat, egg products, dairy products, and vegetable oils such as corn and safflower, and are essential to our diet.
ω−3脂肪酸を含む食品は、大豆、なたね油などに8〜
10%含まれるほか、シソ、エゴマ、アマ二泊などであ
り、さらに海産魚類や海藻類に多く含まれている。しか
し、これらの食品は、昔は、比較的よく摂取されていた
が、現在の我々の食卓には、あまり上がって来ないもの
ばかりである。Foods containing omega-3 fatty acids include soybeans, rapeseed oil, etc.
In addition to 10% of the content, it is also found in perilla, perilla, and flaxseed, and is also found in large amounts in marine fish and seaweed. However, although these foods were relatively commonly consumed in the past, they are not often found on our dining tables today.
これらω−3脂肪酸およびω−6脂肪酸は、いずれも人
体内では生合威ができず、しかも両脂肪酸系統の間では
相互変換がなく、体内におけるω3、ω−6の比率は全
く食物のそれを反映している。Neither these ω-3 fatty acids nor ω-6 fatty acids can be synthesized in the human body, and there is no mutual conversion between the two fatty acid systems, so the ratio of ω-3 and ω-6 in the body is completely that of food. is reflected.
最近の日本人の食生活は欧米型化が進み、肉類を中心と
した食事の機会が大幅に増え、脂肪の摂取量については
一日当り40gと1曽力{1し、それに伴い、疾病の種
類も変化し、高血圧、心臓病のWU環器系疾患や乳癌、
大腸癌などが増加して、こちらも欧米型化になり、大き
な社会問題になっている。Recently, the Japanese diet has become more Western-style, and opportunities to eat meat-based meals have greatly increased, and the amount of fat intake has increased to 40g per day, which has led to an increase in the types of diseases. changes, including high blood pressure, heart disease, cardiovascular disease, and breast cancer.
Colon cancer and other cancers are on the rise, and this has become more Western-style and has become a major social problem.
これらの疾病の原因は、脂肪酸の摂取過多と考えられて
いた。しかし、研究が進むにつれて、脂肪を構或する不
飽和脂肪酸の種類の摂取アンハランスによることが判明
した。これは肉頻に多く含まれるω−6脂肪酸であるア
ラキドン酸から産生される2型のプロスタグランジンや
ロイコトリエンなどが過剰になり、ω−3脂肪酸によっ
て産出される3型のプロスタグランジンやロイコトリエ
ンとのバランスがくずれる事による。The cause of these diseases was thought to be excessive intake of fatty acids. However, as research progressed, it became clear that this was due to an imbalance in the intake of unsaturated fatty acids that make up fat. This is due to an excess of type 2 prostaglandins and leukotrienes produced from arachidonic acid, an omega-6 fatty acid that is abundant in meat, and type 3 prostaglandins and leukotrienes produced from omega-3 fatty acids. This is due to the imbalance between
このような食習慣を考慮して、エイコサペンクエン酸を
高濃度に濃縮した油脂をカプセルに詰めた健康食品や、
鶏に魚油を食べさセてエイコサペンクエン酸やドコサヘ
キサエン酸の含量を高めた卵など、ω−3脂肪酸を強化
した食品の開発がなされてきた。Taking these dietary habits into consideration, we have developed health foods containing capsules containing highly concentrated eicosapencitric acid,
Foods enriched with omega-3 fatty acids have been developed, such as eggs made by feeding chickens with fish oil to increase the content of eicosapencitric acid and docosahexaenoic acid.
(発明が解決しようとする課題)
ω−6脂肪酸の過剰摂取は、PGF2α、TXA2など
の2型プ口スタグランジンやロイコトリエンの産生を促
し、血小板凝集や血管収縮を起こし動脈硬化や血栓症を
誘発する。しかしω−3脂肪酸は逆に、これらの疾患を
抑制したり、更に、乳癌や大腸癌の発癌率を抑えたり(
L. M. Brander& K. K. Carr
oll, Lipids 2L 285(1985),
R. LKarmali et. al.+ J.
Natl. Cancer Inst.+ 73+45
7 (1984)) 、癌細胞の転移能を低下させる(
T.Hori et. al., Chem. Pha
rm. Bull135+ 3925(1987))こ
とが報告されている。(Problem to be solved by the invention) Excessive intake of ω-6 fatty acids promotes the production of type 2 protein staglandins and leukotrienes such as PGF2α and TXA2, which causes platelet aggregation and vasoconstriction, leading to arteriosclerosis and thrombosis. . However, ω-3 fatty acids, on the contrary, suppress these diseases, and even suppress the carcinogenic rate of breast cancer and colorectal cancer (
L. M. Brander & K. K. Carr
oll, Lipids 2L 285 (1985),
R. L Karmali et. al. +J.
Natl. Cancer Inst. +73+45
7 (1984)), which reduces the metastatic potential of cancer cells (
T. Hori et. al. , Chem. Pha
rm. Bull 135+ 3925 (1987)).
高度不飽和脂肪酸から誘導されるプロスタグランジン、
ロイコトリエン、トロンボキサンなどは局所ホルモンと
いわれ腎臓、肝臓、血管内などの細胞で生産され、解熱
作用、血小板凝集、血小板凝集抑制、血圧上昇、血圧降
下などの相反する作用を有し、互いがバランスをとりな
がら生体の恒常性を正常に保っている。しかし、そのハ
ランスがくずれることによって、血栓症や心筋梗塞、高
血圧、免疫性疾患(糖尿病、喘息、乾唐症〉、アレルギ
ー症状などが顕在化する。気をつUなければならないの
は、ω−3脂肪酸ばかりを摂取するのではなく、ω−3
脂肪酸とω−6脂肪酸をバランス良く摂取することであ
る。prostaglandins derived from highly unsaturated fatty acids,
Leukotrienes, thromboxane, etc. are called local hormones and are produced in cells in the kidney, liver, blood vessels, etc., and have contradictory effects such as antipyretic action, platelet aggregation, inhibition of platelet aggregation, increase in blood pressure, and decrease in blood pressure, and they work in balance. It maintains normal homeostasis of the body while taking However, when this harrance collapses, thrombosis, myocardial infarction, high blood pressure, immune diseases (diabetes, asthma, dry skin syndrome), allergic symptoms, etc. become apparent.What we must be careful about is ω- Instead of consuming only 3 fatty acids, ω-3 fatty acids
It is important to intake fatty acids and ω-6 fatty acids in a well-balanced manner.
しかし、前述のように現在の日本人の食事はω6脂肪酸
の摂取に偏っている。However, as mentioned above, the current Japanese diet is biased toward intake of omega-6 fatty acids.
この状態を改善するためにω−3脂肪酸などを高濃度に
濃縮して添加した食品や栄養補助剤などが開発された。In order to improve this condition, foods and nutritional supplements containing highly concentrated omega-3 fatty acids have been developed.
しかしこれらの製品を過度に摂取した場合、逆にω−3
脂肪酸の過剰摂取につながり新たな疾病の原因となる。However, if these products are consumed excessively, ω-3
This leads to excessive intake of fatty acids and causes new diseases.
そこでω−3、ω6脂肪酸の適正な比率での摂取が必要
である。Therefore, it is necessary to intake omega-3 and omega-6 fatty acids in an appropriate ratio.
本発明は、ω−3脂肪酸とω−6脂肪酸をバランス良く
摂取することができ、前述の疾病の予防や改善に効果が
期待されるように、脂質の脂肪酸組或を適正比率に調整
した食品を提供することを目的とする。The present invention is a food product in which the fatty acid composition of lipids is adjusted to an appropriate ratio so that ω-3 fatty acids and ω-6 fatty acids can be ingested in a well-balanced manner and is expected to be effective in preventing and improving the above-mentioned diseases. The purpose is to provide
(課題を解決するための手段)
本発明の食品は、脂肪酸組或をω−3脂肪酸とω−6脂
肪酸との比が1=1〜1:5になるように調整した高度
不飽和脂肪酸を含むことを特徴とする。(Means for Solving the Problems) The food of the present invention contains highly unsaturated fatty acids whose fatty acid composition is adjusted such that the ratio of ω-3 fatty acids to ω-6 fatty acids is 1=1 to 1:5. It is characterized by containing.
本発明に使用されるω−3脂肪酸はイワシ柚、カツオ油
、イカ油、タラ肝油、メンハーデン油などの海産動物由
来の脂質から得られる高度不飽和脂肪酸が挙げられ、例
えばドコサヘキサエン酸、エイコサペンクエン酸、α−
リノレン酸などが−・般的ではあるが、その給源は海藻
や微生物、動物、植物などに限定されるものではない。The ω-3 fatty acids used in the present invention include highly unsaturated fatty acids obtained from lipids derived from marine animals such as sardine yuzu, bonito oil, squid oil, cod liver oil, and menhaden oil, such as docosahexaenoic acid and eicosapene. Citric acid, α-
Linolenic acid and the like are common, but their sources are not limited to seaweed, microorganisms, animals, plants, etc.
さらにそのような油脂を物理的、化学的、生物学的な手
法によってドコサヘキサエン酸、エイコサペンクエン酸
を高濃度に濃縮したものであっても問題はない。Furthermore, there is no problem even if such fats and oils are concentrated to a high concentration of docosahexaenoic acid and eicosapencitric acid by physical, chemical, or biological methods.
またα−リノレン酸などについても植物由来のものが一
般とされてはいるが微生物、動物など、その給源につい
ては問わない。一方、ω−6脂肪酸はその代表例として
リノール酸やγ−リノレン酸などの高度不飽和脂肪酸が
挙げられるが、その給源は微生物や植物、動物などがあ
り、特に限定されるものではない。また食品の形態も後
述の実施例に限定されるものではない。Furthermore, α-linolenic acid and the like are generally derived from plants, but their sources such as microorganisms and animals are not concerned. On the other hand, representative examples of ω-6 fatty acids include highly unsaturated fatty acids such as linoleic acid and γ-linolenic acid, but their sources include microorganisms, plants, and animals, and are not particularly limited. Furthermore, the form of the food is not limited to the examples described below.
本発明の食品の脂肪酸m戒は、ω−3脂肪酸とω−6脂
肪酸との比がl:1〜1:5になるように調整する。こ
の範囲よりも小さいときは、ω3脂肪酸が過剰になり、
この範囲よりも大きいときはω−6脂肪酸が過剰になっ
てしまい、いずれの場合もω−3脂肪酸とω−6脂肪酸
との摂取ハランスが崩れてしまうので好ましくない。The fatty acid ratio of the food of the present invention is adjusted so that the ratio of ω-3 fatty acids to ω-6 fatty acids is 1:1 to 1:5. When it is smaller than this range, ω3 fatty acids become excessive,
If it is larger than this range, ω-6 fatty acids will become excessive, and in either case, the intake balance between ω-3 fatty acids and ω-6 fatty acids will be disrupted, which is not preferable.
(発明の効果)
本発明によれば、食品に含有される脂質のω3、ω−6
脂肪酸の比率を適正比率であるl:1〜1:5に保つよ
うに調製された食品を提供することができるので、ω−
3脂肪酸とω−6脂肪酸をバランス良く摂取することが
でき、高血圧、心臓病の循環器系疾患や乳癌、大腸癌な
どの疾病の予防や改善に効果が期待される。(Effect of the invention) According to the present invention, ω3 and ω-6 of lipids contained in food
Since it is possible to provide foods prepared to maintain the ratio of fatty acids at an appropriate ratio of 1:1 to 1:5, ω-
It allows for a well-balanced intake of 3 fatty acids and ω-6 fatty acids, and is expected to be effective in preventing and improving diseases such as high blood pressure, cardiovascular disease, breast cancer, and colon cancer.
(実施例) 以下、実施例に基づき、本発明を具体的に説明する。(Example) Hereinafter, the present invention will be specifically explained based on Examples.
実施例l
(マーガリン)
タラ肝油をウィンクリングした油脂(IV 143.6
、POV O.80、エイコサペンタエンM 9.8%
、ドコサール300ppm (エーザイ■製)を添加し
たものを用意し、これに米ぬか油(IV 101, P
OV O.41、オレイン酸45.4%、リノール酸3
6.9%)13g、り゜フラワー油(IV 139、P
OV O.44、リノール酸75.4%)32gを添加
して、均一になるまで撹拌した。この油に14gの水と
2gの牛乳、若干の食塩、モノグリセライド、さらに4
,50010のビタミンAを添加して撹拌し、W/O型
のエマルションを作った。Example 1 (Margarine) Winkling cod liver oil (IV 143.6
, POV O. 80, Eicosapentaene M 9.8%
, Docosal 300ppm (manufactured by Eisai) was prepared, and rice bran oil (IV 101, P
OV O. 41, oleic acid 45.4%, linoleic acid 3
6.9%) 13g, Riwa flower oil (IV 139, P
OV O. 44, linoleic acid 75.4%) was added and stirred until uniform. Add to this oil 14g of water, 2g of milk, some salt, monoglyceride, and 4
, 50010 of vitamin A was added and stirred to prepare a W/O emulsion.
このマーガリンを冷蔵庫中で約150日間保存したが、
風味には殆ど変化が見られなかった。This margarine was stored in the refrigerator for about 150 days,
Almost no change was observed in flavor.
このマーガリンに含有されるω−3脂肪酸とω6脂肪酸
の比率は、ほぼ1:3であった。The ratio of ω-3 fatty acids to ω6 fatty acids contained in this margarine was approximately 1:3.
実施例2
〈ソーセージ)
カツオカラ精製した魚油(IV 190.2、POV
O.56、エイコサペンクエン酸6.3%、ドコサヘキ
サエン酸26.9%)10gに、抗酸化剤としてジンク
ス1・コフェロール(エーザイ■製)を200ppm添
加したもノオよびサフラワー油(IV 139、POV
O.44、リノール酸75.4%) 8.4gを混合
したものを用意した。Example 2 (Sausage) Refined Bonito Kara fish oil (IV 190.2, POV
O. 56, eicosapen citric acid 6.3%, docosahexaenoic acid 26.9%) 10g, and 200ppm of Zinc 1 Copherol (manufactured by Eisai ■) as an antioxidant was added to the oil and safflower oil (IV 139, POV
O. 44, linoleic acid 75.4%) was mixed with 8.4 g.
次に市販のスケトウダラの冷凍すり身1 kgをよく練
り混ぜながら、食塩23gを加えた。これに、先に用意
したカツオ魚油10gとサフラワー油8.4gを混合し
たものを徐々に添加して、よく練り込めた。Next, 23 g of common salt was added while thoroughly kneading 1 kg of commercially available frozen pollack surimi. To this, a mixture of 10 g of bonito fish oil and 8.4 g of safflower oil prepared earlier was gradually added and mixed well.
さらに、ジャガイモデンプン80gとグルタくン酸ナト
リウム5g、冷水300gを加え良く練り込んだ。Furthermore, 80 g of potato starch, 5 g of sodium glutamate, and 300 g of cold water were added and kneaded well.
以上の配合割合で練り合わせたものを内径48m/mの
塩化ビニリデンフィルムに約100g充填し、90℃で
40分間加熱後、冷却し、ソーセージを製造した。Approximately 100 g of the mixture kneaded at the above mixing ratio was filled into a vinylidene chloride film having an inner diameter of 48 m/m, heated at 90° C. for 40 minutes, and then cooled to produce a sausage.
このソーセージに含有される脂質のω−3、ω6の比率
はほぼ1:1.5であった。また、味、匂いともに良好
であった。The ratio of ω-3 and ω6 lipids contained in this sausage was approximately 1:1.5. Moreover, both taste and smell were good.
実施例3
(マヨネーズ)
エゴマから精製した油(IV 183、POV O.1
9、αリノレン酸55.9%)50gに抗酸化剤として
緑茶のアセトン抽出物300ppmを添加したものを用
意した。また、月見草から精製した油(IV 104、
POvO.23、リノール酸71.1%、γ−リノレン
酸10.0%)9
30gを用意した。このエゴマ油と月見草油を加えて混
合油を作った。次に、卵黄6.5g、食酢5. 0g、
食塩1.5g、砂tJ!1.0g、水5.95g、グル
タミン酸ナトリウム0.05g、香辛料少々をそれぞれ
加えて良くかき混ぜた。Example 3 (Mayonnaise) Oil refined from perilla (IV 183, POV O.1
9. 50 g of α-linolenic acid (55.9%) was prepared by adding 300 ppm of green tea acetone extract as an antioxidant. Also, oil refined from evening primrose (IV 104,
POvO. 23, linoleic acid 71.1%, γ-linolenic acid 10.0%) 9 30g was prepared. I made a mixed oil by adding this perilla oil and evening primrose oil. Next, add 6.5g of egg yolk and 5.5g of vinegar. 0g,
1.5g of salt, sand tJ! 1.0 g of water, 5.95 g of water, 0.05 g of monosodium glutamate, and a few spices were added and stirred well.
これらを激しく撹拌しながら、先ほどの混合油を少量ず
つ滴下し、マヨネーズを作った。このマヨネーズを冷蔵
庫中で約150日保存したが、風味は殆ど変化していな
かった。While vigorously stirring these, the mixed oil from earlier was added dropwise little by little to make mayonnaise. This mayonnaise was stored in the refrigerator for about 150 days, but the flavor did not change much.
このマヨネーズに含有されるω−3、ω−6脂肪酸の比
率は、ほぼ1:lであった。The ratio of ω-3 and ω-6 fatty acids contained in this mayonnaise was approximately 1:1.
実施例4
(ドリンク剤)
カツオ魚油をウィンクリングしてω−3脂肪酸を濃縮し
た油脂(IV 190.2、POV O.56、エイコ
サヘンクエン酸6.3%、ドコサヘキサエン酸26.9
%)15gにミソクストコフェロール300ppmを抗
酸化剤として添加した。さらに月見草油(IV 104
、POvO.23、リノール酸71.1%、T−リノレ
ン酸10.0%)を35g加えて混合油を作った。β−
サイクロデキ10
ストリン100gに、水100 mAを加えて撹拌後、
先の混合油を加えてホモジナイザーで約25分間混練し
た。エタノールで2回洗浄して、沈澱を集めた。Example 4 (Drink) Oil and fat obtained by winking bonito fish oil and concentrating ω-3 fatty acids (IV 190.2, POV O.56, eicosahencitric acid 6.3%, docosahexaenoic acid 26.9)
%) 300 ppm of misoxtocopherol was added to 15 g as an antioxidant. In addition, evening primrose oil (IV 104
, POvO. 23, 71.1% linoleic acid, 10.0% T-linolenic acid) was added to make a mixed oil. β-
After adding 100 mA of water to 100 g of Cyclodeki 10 String and stirring,
The above mixed oil was added and kneaded using a homogenizer for about 25 minutes. The precipitate was collected by washing twice with ethanol.
この沈澱を室温で減圧乾燥して混合油のサイクロデキス
トリン粉末を約70g得た。このサイクロデキストリン
粉末を次表に示す組威のドリンク剤に添加した。この時
のサイクロデキストリン粉末のドリンク剤への分散は3
%程度まで容易であった。This precipitate was dried under reduced pressure at room temperature to obtain about 70 g of mixed oil cyclodextrin powder. This cyclodextrin powder was added to the drinks shown in the table below. At this time, the dispersion of cyclodextrin powder into the drink was 3
% was easy.
また、含有脂質中のω−3、ω−6脂肪酸の比率は、ほ
ぼ1:4であった。さらに粉末のドリンク剤を冷蔵庫に
て約150日保存したが、その風味には大きな変化は認
められなかった。Furthermore, the ratio of ω-3 and ω-6 fatty acids in the contained lipids was approximately 1:4. Further, the powdered drink was stored in the refrigerator for about 150 days, but no major change in flavor was observed.
表 ドリンク剤の組威 0.85g/ j2 0.35g/ 1 0. 15g/ 1 0. 15g/ A 1.35g/ A’ 1.10g/Il 0.05g/ 1 NaCI MCI CaClz MgC1. クエン酸 クエン酸ソーダ L−グルタξン酸ソーダ 1 l グルコース 砂糖 果汁 20g/ !V 20g/N 30g/j!Table: Strength of drink preparations 0.85g/j2 0.35g/1 0. 15g/1 0. 15g/A 1.35g/A’ 1.10g/Il 0.05g/1 NaCI MCI CaClz MgC1. citric acid citric acid soda Sodium L-glutamate 1 l glucose sugar fruit juice 20g/! V 20g/N 30g/j!
Claims (1)
比が1:1〜1:5になるように調整した高度不飽和脂
肪酸を含む食品。A food containing highly unsaturated fatty acids whose fatty acid composition is adjusted so that the ratio of ω-3 fatty acids to ω-6 fatty acids is 1:1 to 1:5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1187256A JPH0353869A (en) | 1989-07-21 | 1989-07-21 | Food containing highly unsaturated fatty acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1187256A JPH0353869A (en) | 1989-07-21 | 1989-07-21 | Food containing highly unsaturated fatty acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0353869A true JPH0353869A (en) | 1991-03-07 |
Family
ID=16202789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1187256A Pending JPH0353869A (en) | 1989-07-21 | 1989-07-21 | Food containing highly unsaturated fatty acid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0353869A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08228678A (en) * | 1995-02-23 | 1996-09-10 | Taiyo Kagaku Co Ltd | Emulsified composition |
| JPH09121766A (en) * | 1995-10-31 | 1997-05-13 | Meiji Milk Prod Co Ltd | Infant food with adjusted n-6 series / n-3 series fatty acid ratio |
| EP1046341A1 (en) * | 1999-04-19 | 2000-10-25 | GE.FIN. S.A. Società Finanziaria Fiduciaria | Food composition with a high polyunsaturated fatty acid content, its preparations and use in a proper alimentary diet |
| WO2003056939A1 (en) * | 2002-01-10 | 2003-07-17 | Puleva Biotech, S.A. | Oil blends |
| JP2004035456A (en) * | 2002-07-03 | 2004-02-05 | Pola Chem Ind Inc | Promoter for keratinocyte maturation and oral administration composition containing the same |
| KR100654528B1 (en) * | 2001-02-21 | 2006-12-05 | 다이니치 세이카 고교 가부시키가이샤 | Resin compositions and molded products making use of the same |
| JP2008520221A (en) * | 2004-11-16 | 2008-06-19 | ウニベルシダッド アウトノマ デ マドリッド | Oily mixture of natural bioactive ingredients for the preparation of fortified foods |
| JP2008228732A (en) * | 2007-03-20 | 2008-10-02 | Coy Johannes | Beverage |
| JP2011518223A (en) * | 2008-04-21 | 2011-06-23 | アーシャ リピッド サイエンシーズ, インコーポレイテッド | Lipid-containing composition and method of use thereof |
| JP2013517234A (en) * | 2010-01-12 | 2013-05-16 | インデナ エッセ ピ ア | A composition comprising an extract of sensinren (Andrographicspaniculata) and a ginkgo extract complexed with phospholipids |
| WO2016067804A1 (en) * | 2014-10-30 | 2016-05-06 | 不二製油グループ本社株式会社 | Long-chain polyunsaturated fatty-acid-containing fat and food containing same |
-
1989
- 1989-07-21 JP JP1187256A patent/JPH0353869A/en active Pending
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08228678A (en) * | 1995-02-23 | 1996-09-10 | Taiyo Kagaku Co Ltd | Emulsified composition |
| JPH09121766A (en) * | 1995-10-31 | 1997-05-13 | Meiji Milk Prod Co Ltd | Infant food with adjusted n-6 series / n-3 series fatty acid ratio |
| EP1046341A1 (en) * | 1999-04-19 | 2000-10-25 | GE.FIN. S.A. Società Finanziaria Fiduciaria | Food composition with a high polyunsaturated fatty acid content, its preparations and use in a proper alimentary diet |
| KR100654528B1 (en) * | 2001-02-21 | 2006-12-05 | 다이니치 세이카 고교 가부시키가이샤 | Resin compositions and molded products making use of the same |
| WO2003056939A1 (en) * | 2002-01-10 | 2003-07-17 | Puleva Biotech, S.A. | Oil blends |
| JP2004035456A (en) * | 2002-07-03 | 2004-02-05 | Pola Chem Ind Inc | Promoter for keratinocyte maturation and oral administration composition containing the same |
| JP2008520221A (en) * | 2004-11-16 | 2008-06-19 | ウニベルシダッド アウトノマ デ マドリッド | Oily mixture of natural bioactive ingredients for the preparation of fortified foods |
| JP2008228732A (en) * | 2007-03-20 | 2008-10-02 | Coy Johannes | Beverage |
| JP2011518223A (en) * | 2008-04-21 | 2011-06-23 | アーシャ リピッド サイエンシーズ, インコーポレイテッド | Lipid-containing composition and method of use thereof |
| JP2014176385A (en) * | 2008-04-21 | 2014-09-25 | Asha Nutrition Sciences Inc | Lipid-containing composition and method for using the same |
| JP2018064563A (en) * | 2008-04-21 | 2018-04-26 | アーシャ ニュートリション サイエンシーズ, インコーポレイテッド | Lipid-containing compositions and methods of use thereof |
| US10292958B2 (en) | 2008-04-21 | 2019-05-21 | Asha Nutrition Sciences, Inc. | Lipid-containing compositions and methods of use thereof |
| JP2013517234A (en) * | 2010-01-12 | 2013-05-16 | インデナ エッセ ピ ア | A composition comprising an extract of sensinren (Andrographicspaniculata) and a ginkgo extract complexed with phospholipids |
| WO2016067804A1 (en) * | 2014-10-30 | 2016-05-06 | 不二製油グループ本社株式会社 | Long-chain polyunsaturated fatty-acid-containing fat and food containing same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3512196B2 (en) | Food composition comprising a balance regulator for omega-6 and omega-3 unsaturated fatty acids | |
| JP4540672B2 (en) | A composition containing an ingredient derived from salvia sclare seed as an active ingredient | |
| CN108720021A (en) | DHA algal oil microscapsule powder and preparation method thereof | |
| JPWO2010052847A1 (en) | Rich liquid food | |
| WO2012161572A1 (en) | Composition comprising vitamin k2 | |
| CN101897418B (en) | Body taste improver comprising long-chain highly unsaturated fatty acid and/or ester thereof | |
| CN104168772A (en) | Food composition comprising vitamin K and saturated fat and use thereof | |
| JPH0353869A (en) | Food containing highly unsaturated fatty acid | |
| CN102028048A (en) | Deep sea fish oil edible blend oil rich in polyunsaturated fatty acid | |
| US20140371315A1 (en) | Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids | |
| CN104366437B (en) | Be rich in sauce and preparation method thereof of going with rice or bread of n-3 polyunsaturated fatty acid | |
| WO2012145339A2 (en) | Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids | |
| RU2267934C2 (en) | Method for production of natural fish can | |
| Gopal | Foods from the ocean for nutrition, health, and wellness | |
| RU2236157C2 (en) | Meat-based canned food for babies | |
| JPH06169735A (en) | Nutritious drink composition | |
| AU2017323114B2 (en) | Fish odor-free fish oil composition and preparation method therefor | |
| JP2001029010A (en) | Nutrient composition | |
| JPH03297364A (en) | Powdery composition for preventing thrombosis | |
| JPS62224258A (en) | Nourishing food | |
| Sharma et al. | Choosing quality oil for good health and long life. | |
| JPH02227030A (en) | Fatty or oily food enriched with alpha-linolenic acid | |
| JPH0276558A (en) | Alpha-linolenic acid-enriched fish meat sausage | |
| JPS62163669A (en) | Spread food containing eicosapentaenoic acid | |
| JPH02292397A (en) | Edible oil and fat compositions and processed foods |